GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (OTCPK:RCDTF) » Definitions » Price-to-Operating-Cash-Flow

Recordati SpA (Recordati SpA) Price-to-Operating-Cash-Flow : 20.65 (As of May. 01, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Recordati SpA Price-to-Operating-Cash-Flow?

As of today (2024-05-01), Recordati SpA's share price is $51.60. Recordati SpA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.50. Hence, Recordati SpA's Price-to-Operating-Cash-Flow Ratio for today is 20.65.

The historical rank and industry rank for Recordati SpA's Price-to-Operating-Cash-Flow or its related term are showing as below:

RCDTF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.48   Med: 20.67   Max: 34.88
Current: 21.16

During the past 13 years, Recordati SpA's highest Price-to-Operating-Cash-Flow Ratio was 34.88. The lowest was 11.48. And the median was 20.67.

RCDTF's Price-to-Operating-Cash-Flow is ranked worse than
58.79% of 677 companies
in the Drug Manufacturers industry
Industry Median: 17.63 vs RCDTF: 21.16

Recordati SpA's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.40. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.50.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Recordati SpA was 5.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 6.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 11.70% per year.

During the past 13 years, Recordati SpA's highest 3-Year average Operating Cash Flow per Share Growth Rate was 30.40% per year. The lowest was -11.10% per year. And the median was 13.15% per year.


Recordati SpA Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Recordati SpA's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Price-to-Operating-Cash-Flow Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.65 23.49 24.03 17.55 21.04

Recordati SpA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.55 17.86 18.05 18.35 21.04

Competitive Comparison of Recordati SpA's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - General subindustry, Recordati SpA's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Price-to-Operating-Cash-Flow falls into.



Recordati SpA Price-to-Operating-Cash-Flow Calculation

Recordati SpA's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=51.60/2.499
=20.65

Recordati SpA's Share Price of today is $51.60.
Recordati SpA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.50.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Recordati SpA Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA (Recordati SpA) Business Description

Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (Recordati SpA) Headlines

From GuruFocus

Recordati: Isturisa® (Osilodrostat) Approved In The U.S.

By PRNewswire PRNewswire 03-09-2020